Strategic inflection via Emirates NBD, but PAT growth disappoints

Delivered net profit ₹234.2 Cr, YoY growth 9.3%

Not contradicted; loan growth outpaced deposit growth (23% vs 11%)

NIM at 4.13%, down 50 bps over two quarters; guidance is recovery guidance, not achievement

Early delinquencies improving, but cost guidance is forward-looking; no contradiction

₹26,000 Cr capital infusion; strategic shift from independent to EMD subsidiary; reputational uplift via rating upgrades

CFO guided +40-50 bps improvement Q2 as high-cost deposits retire; no such clarity in prior calls (data not provided)

Guided credit costs to 5% handle by Q3 (from prior stress); early delinquencies improving

CFO: 40-50 bps improvement expected Q2 as high-cost wholesale deposits cycle off and rates stabilize. Recovery conditional on RBI policy.

Management guided credit costs to sub-5% by Q3; early delinquency indicators improved meaningfully. Stress peaked Q4 FY26; normalization on track.

Deliberate rundown of high-cost wholesale deposits; EMD capital infusion deployed into short-term instruments for gradual deployment as credit demand rises.

2-3x market share target for FCNR/NRE deposits; incremental low-cost deposits to flow over FY27-28; structural boost to NIM and ROE in 3-4 years.

1% ROA is conditional on margin recovery and cost discipline. Double-digit ROE aspirational, not committed; depends on EMD synergies and scale.

Q1 revenue +11.6% YoY; management guided advances +23% YoY; deposit growth +11% YoY. Near-term growth appears sustainable, moderating as advance/deposit gap normalizes.

High-cost wholesale deposits retiring; RBI policy and rate environment assumptions embedded. Conditional on market rates; early delinquency trends supportive.

EMD capital to be deployed gradually for retail and cross-border growth; no major capex cycles expected FY27.

NIM 4.13%, down 50 bps over 2Q; deposit mix shift from high-cost wholesale ongoing; pricing power limited in competitive retail segment.

Microfinance disbursements up 50% YoY; elevated stress in Q4 FY26-Q1 FY27; normalization assumed Q3 but timing uncertain.

Advances +23% YoY but deposits +11% YoY; gap funded by EMD capital and wholesale rundown; structural mismatch if retail deposits don't accelerate.

60% stake acquisition is transformational; synergy realization (Middle East deposits, cross-border) is 3-4 year aspiration; execution and regulatory risk.

PAT growth only 9.3% YoY; QoQ PAT declined 4.2% despite advance growth +23%. PAT momentum lags operational growth, signaling sustained margin/cost pressure.